Literature DB >> 3793851

Diabetic autonomic neuropathy and impaired human pancreatic polypeptide secretion in response to food.

R Lugari, A Gnudi, P Dall'Argine, A Vattini, G Rignanese, B Dall'Aglio, N Melchionda, P Colella, A Luciani, S Toscani.   

Abstract

In normal subjects, the early human pancreatic polypeptide (hPP) increase induced by food is mainly dependent on vagal activity. Parasympathetic function and plasma hPP response to a standard mixed meal were evaluated in 10 long term insulin-dependent (type I) diabetic patients (group A), 6 age-matched newly diagnosed type I diabetic patients (group B), and 8 normal subjects. The indices of vagal function (beat to beat heart rate variation during deep breathing and the Valsalva maneuver) were uniformly altered in group A, while they were in the normal range in group B, thus excluding in these latter patients the presence of vagal damage. Plasma hPP in response to standard mixed meal was measured at 5, 15, 30, 60, and 120 min. Fasting plasma hPP concentrations (determined by RIA) in groups A and B (mean +/- SEM, 113 +/- 21 and 83 +/- 21 pg/ml, respectively) did not significantly differ from normal (59 +/- 12 pg/ml). In group A, the initial meal-induced hPP increase was significantly lower than normal (5 min, 139 +/- 12; 15 min, 173 +/- 24; 30 min, 137 +/- 17 pg/ml; P less than 0.01 vs. 5 min, 412 +/- 76; 15 min, 446 +/- 57; 30 min, 325 +/- 56 pg/ml). All group B patients had a marked early increase in the peptide, similar to that in the normal subjects. These results suggest that diabetic autonomic neuropathy is associated with dysfunction of hPP secretion, and the evaluation of hPP in response to SMM may be considered a sensitive and nonstressful method for the assessment of parasympathetic impairment in diabetes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3793851     DOI: 10.1210/jcem-64-2-279

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  Utility of the plasma pancreatic polypeptide response to modified sham feeding in diabetic gastroenteropathy and non-ulcer dyspepsia.

Authors:  Anshuman Desai; Phillip A Low; Michael Camilleri; Wolfgang Singer; Duane Burton; Subhankar Chakraborty; Adil E Bharucha
Journal:  Neurogastroenterol Motil       Date:  2019-10-22       Impact factor: 3.598

2.  Autonomic dysfunction in patients with chronic intestinal pseudo-obstruction.

Authors:  M Camilleri; R K Balm; P A Low
Journal:  Clin Auton Res       Date:  1993-04       Impact factor: 4.435

3.  Cholecystokinin and pancreatic polypeptide release in diabetic patients with and without autonomic neuropathy.

Authors:  B Glasbrenner; E Dominguez-Munoz; R L Riepl; A Vetsi; P Malfertheiner
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.